|
2019-10-24 |
2019-10-22 |
B
Purchase
|
H LUNDBECK A S
Large shareholder
|
85,923,561
0.00
USD 0
|
85,923,561
|
0.00
|
USD 0
|
|
|
2019-09-18 |
2019-09-16 |
PS
Planned sale
|
Smith Jeffrey T L
Managing Director
|
32,728
-86.1%
18.44
USD 603,504
|
32,728
-86.1%
|
18.44
|
USD 603,504
|
|
|
2019-04-25 |
2019-04-25 |
PS
Planned sale
|
Benedict Larry
EVP and PAO
|
1,734
-4.2%
13.65
USD 23,662
|
1,734
-4.2%
|
13.65
|
USD 23,662
|
|
|
2019-04-25 |
2019-04-25 |
PS
Planned sale
|
Lavelle Erin
Chief Operating Officer
|
1,434
-24.5%
13.67
USD 19,599
|
1,434
-24.5%
|
13.67
|
USD 19,599
|
|
|
2019-04-25 |
2019-04-25 |
PS
Planned sale
|
Hassler Randal
EVP, Pharmaceutical Ops.
|
1,738
-24.2%
13.85
USD 24,067
|
1,738
-24.2%
|
13.85
|
USD 24,067
|
|
|
2019-04-25 |
2019-04-25 |
PS
Planned sale
|
Bucher James B
EVP & General Counsel
|
1,897
-16.2%
13.85
USD 26,281
|
1,897
-16.2%
|
13.85
|
USD 26,281
|
|
|
2018-12-04 |
2018-12-03 |
PS
Planned sale
|
Smith Jeffrey T L
Managing Director
Officer
|
5,044
-85.9%
13.84
USD 69,826
|
5,044
-85.9%
|
13.84
|
USD 69,826
|
|
|
2018-11-05 |
2018-11-01 |
PS
Planned sale
|
Latham John A
Chief Scientific Officer
Officer
|
1,319
-0.5%
13.78
USD 18,170
|
1,319
-0.5%
|
13.78
|
USD 18,170
|
|
|
2018-11-05 |
2018-11-01 |
PS
Planned sale
|
Latham John A
Chief Scientific Officer
Officer
|
23,683
-8.8%
13.40
USD 317,419
|
23,683
-8.8%
|
13.40
|
USD 317,419
|
|
|
2018-11-05 |
2018-11-01 |
PS
Planned sale
|
Smith Jeffrey T L
Managing Director
Officer
|
5,040
-85.8%
13.42
USD 67,637
|
5,040
-85.8%
|
13.42
|
USD 67,637
|
|
|
2018-10-03 |
2018-10-01 |
PS
Planned sale
|
Smith Jeffrey T L
Managing Director
Officer
|
2,000
-70.6%
15.97
USD 31,944
|
2,000
-70.6%
|
15.97
|
USD 31,944
|
|
|
2018-10-03 |
2018-10-01 |
PS
Planned sale
|
Smith Jeffrey T L
Managing Director
Officer
|
3,040
-51.8%
15.26
USD 46,385
|
3,040
-51.8%
|
15.26
|
USD 46,385
|
|
|
2018-10-03 |
2018-10-01 |
PS
Planned sale
|
Latham John A
Chief Scientific Officer
Officer
|
6,554
-2.6%
15.97
USD 104,692
|
6,554
-2.6%
|
15.97
|
USD 104,692
|
|
|
2018-10-03 |
2018-10-01 |
PS
Planned sale
|
Latham John A
Chief Scientific Officer
Officer
|
18,445
-6.9%
15.25
USD 281,314
|
18,445
-6.9%
|
15.25
|
USD 281,314
|
|
|
2018-09-06 |
2018-09-04 |
PS
Planned sale
|
Latham John A
Chief Scientific Officer
Officer
|
24,999
-9.3%
17.99
USD 449,680
|
24,999
-9.3%
|
17.99
|
USD 449,680
|
|
|
2018-09-06 |
2018-09-04 |
PS
Planned sale
|
Smith Jeffrey T L
Managing Director
Officer
|
5,040
-85.8%
18.00
USD 90,699
|
5,040
-85.8%
|
18.00
|
USD 90,699
|
|
|
2018-08-02 |
2018-08-01 |
PS
Planned sale
|
Smith Jeffrey T L
Managing Director
Officer
|
980
-54.1%
19.76
USD 19,369
|
980
-54.1%
|
19.76
|
USD 19,369
|
|
|
2018-08-02 |
2018-08-01 |
PS
Planned sale
|
Smith Jeffrey T L
Managing Director
Officer
|
4,060
-69.2%
19.49
USD 79,120
|
4,060
-69.2%
|
19.49
|
USD 79,120
|
|
|
2018-08-02 |
2018-08-01 |
PS
Planned sale
|
Latham John A
Chief Scientific Officer
Officer
|
24,999
-9.3%
19.55
USD 488,768
|
24,999
-9.3%
|
19.55
|
USD 488,768
|
|
|
2018-07-03 |
2018-07-02 |
PS
Planned sale
|
Smith Jeffrey T L
Managing Director
Officer
|
12,161
-93.6%
15.49
USD 188,364
|
12,161
-93.6%
|
15.49
|
USD 188,364
|
|
